A Phase I Study to Evaluate Two Doses of Wharton's Jelly-Derived Mesenchymal Stromal Cells for the Treatment of De Novo High-Risk or Steroid-Refractory Acute Graft Versus Host Disease. Stem Cell Rev Rep. 2020.
Suppression of hematopoietic primitive cells in patients with secondary failure of platelet recovery after acute graft versus host disease. Biol Blood Marrow Transplant. 2020.
All-Trans Retinoic Acid-Induced Deficiency of the Wnt/β-Catenin Pathway Enhances Hepatic Carcinoma Stem Cell Differentiation. PLoS One. 2015;10(11):e0143255..